Magalie Joris

1.5k total citations
22 papers, 223 citations indexed

About

Magalie Joris is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, Magalie Joris has authored 22 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 5 papers in Surgery and 4 papers in Genetics. Recurrent topics in Magalie Joris's work include Acute Myeloid Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Magalie Joris is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Magalie Joris collaborates with scholars based in France, Belgium and United Kingdom. Magalie Joris's co-authors include Thierry Soupison, B. De Cagny, Dimitri Titeca‐Beauport, Loay Kontar, Antoine Rivière, Michel Slama, Pablo Mercado, Julien Maizel, Christophe Beyls and Christophe Tribouilloy and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Critical Care Medicine.

In The Last Decade

Magalie Joris

20 papers receiving 219 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magalie Joris France 8 113 77 69 49 38 22 223
Murray Kornbluth Canada 6 114 1.0× 182 2.4× 41 0.6× 32 0.7× 9 0.2× 9 301
Karen MacKinnon Canada 8 67 0.6× 117 1.5× 15 0.2× 86 1.8× 59 1.6× 10 332
Zachary W. Fitch United States 11 203 1.8× 40 0.5× 32 0.5× 50 1.0× 11 0.3× 35 397
Francesco Sollitto Italy 13 139 1.2× 30 0.4× 16 0.2× 72 1.5× 5 0.1× 37 402
Alfonsa Friera Spain 8 165 1.5× 40 0.5× 54 0.8× 63 1.3× 13 0.3× 11 326
Laura Franco Italy 12 97 0.9× 214 2.8× 8 0.1× 56 1.1× 38 1.0× 25 388
Chiara Simion Italy 10 62 0.5× 49 0.6× 10 0.1× 29 0.6× 68 1.8× 24 271
Jacqueline Szmuszkovicz United States 8 132 1.2× 58 0.8× 18 0.3× 22 0.4× 9 0.2× 23 218
Shin-Yup Lee South Korea 12 43 0.4× 99 1.3× 74 1.1× 119 2.4× 10 0.3× 26 389
V. Villena Spain 9 94 0.8× 33 0.4× 36 0.5× 46 0.9× 5 0.1× 15 365

Countries citing papers authored by Magalie Joris

Since Specialization
Citations

This map shows the geographic impact of Magalie Joris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magalie Joris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magalie Joris more than expected).

Fields of papers citing papers by Magalie Joris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magalie Joris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magalie Joris. The network helps show where Magalie Joris may publish in the future.

Co-authorship network of co-authors of Magalie Joris

This figure shows the co-authorship network connecting the top 25 collaborators of Magalie Joris. A scholar is included among the top collaborators of Magalie Joris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magalie Joris. Magalie Joris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joris, Magalie, et al.. (2024). Evaluation of the immature platelet fraction as a predictive marker of bone marrow regeneration after hematopoietic stem cell transplantation. International Journal of Laboratory Hematology. 47(1). 41–50.
2.
Chevret, Sylvie, Xavier Poiré, Magalie Joris, et al.. (2024). Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. Bone Marrow Transplantation. 59(7). 965–973.
3.
Durand, G, Magalie Joris, A Charbonnier, et al.. (2024). Platelet transfusions in haploidentical haematopoietic stem cell allograft candidates: Protecting HLA‐A and HLA‐B antigens through eplet analysis. HLA. 103(3). e15438–e15438. 1 indexed citations
4.
Fenwarth, Laurène, Delphine Lebon, Nicolas Duployez, et al.. (2023). The Occurrence of Infection and TP53 Mutation Are Risk Factors for Cardiovascular Toxicity of Acute Myeloid Leukemia Induction Therapy. Blood. 142(Supplement 1). 3815–3815. 1 indexed citations
5.
Beauvais, David, Anne Thiébaut, Sophie Alain, et al.. (2022). Effective Letermovir Prophylaxis of CMV infection post allogeneic hematopoietic cell transplantation: Results from the French temporary authorization of use compassionate program. Journal of Clinical Virology. 148. 105106–105106. 12 indexed citations
6.
Lebon, Delphine, Alexis Caulier, Magalie Joris, et al.. (2022). Ruxolitinib-induced reactivation of cytomegalovirus and Epstein-Barr virus in graft-versus-host disease. Leukemia Research. 125. 107005–107005. 3 indexed citations
7.
Sekeres, Mikkael A., Michael Schuster, Magalie Joris, et al.. (2022). A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes. Annals of Hematology. 101(8). 1689–1701. 11 indexed citations
8.
Houot, Roch, Emmanuel Bachy, Guillaume Cartron, et al.. (2022). Axicabtagene Ciloleucel As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients: Primary Analysis of Alycante, a Phase 2 Lysa Study. Blood. 140(Supplement 1). 410–411. 7 indexed citations
9.
Caulier, Alexis, Magalie Joris, A Charbonnier, et al.. (2021). Negative MRD at Day 100 after Allogenic Hematopoietic Stem Cell Transplant (HSCT): The Grail to Reach in Acute Myeloid Leukemia (AML). Blood. 138(Supplement 1). 2928–2928. 1 indexed citations
10.
Maillard, Alexis, Rabah Redjoul, Hélène Labussière, et al.. (2021). Antibody Response to 2-Dose Sars-Cov-2 mRNA Vaccine in Allogeneic Hematopoietic Cell Transplant Recipients. Blood. 138(Supplement 1). 336–336. 1 indexed citations
11.
12.
Joris, Magalie, et al.. (2020). Oral and Poster Presentations. HLA. 95(4). 272–422. 3 indexed citations
13.
Mercado, Pablo, Julien Maizel, Christophe Beyls, et al.. (2020). Doppler Echocardiographic Indices Are Specific But Not Sensitive to Predict Pulmonary Artery Occlusion Pressure in Critically Ill Patients Under Mechanical Ventilation. Critical Care Medicine. 49(1). e1–e10. 7 indexed citations
14.
Zeidan, Amer M., Michael W. Schuster, Jürgen Krauter, et al.. (2019). Clinical Benefit of Glasdegib in Combination with Azacitidine or Low-Dose Cytarabine in Patients with Acute Myeloid Leukemia. Blood. 134(Supplement_1). 3916–3916. 10 indexed citations
15.
Sekeres, Mikkael A., Michael W. Schuster, Magalie Joris, et al.. (2019). A Phase 1b Study of Glasdegib in Combination with Azacitidine in Patients with Untreated Higher-Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia. Blood. 134(Supplement_1). 177–177. 16 indexed citations
16.
Joris, Magalie, et al.. (2019). The lenalidomide/bortezomib/dexamethasone regimen for the treatment of blastic plasmacytoid dendritic cell neoplasm. Hematological Oncology. 37(4). 487–489. 20 indexed citations
17.
Joris, Magalie, Delphine Lebon, A Charbonnier, et al.. (2019). Immunomodulation with Azacytidine and Donor Lymphocyte Infusion Following Sequential Conditioning Allogenic Stem Cell Transplantation Improves Outcome of Unfavorable AML. Blood. 134(Supplement_1). 4600–4600. 3 indexed citations
18.
Morel, Pierre, Alexis Caulier, Magalie Joris, et al.. (2019). Fast CMV and EBV Reactivations after Ruxolitinib for Graft-Versus-Host Disease Treatment. Blood. 134(Supplement_1). 2007–2007. 1 indexed citations
19.
Karam, J.D., et al.. (2018). Spontaneous tumour lysis syndrome in a primary adrenal lymphoma. British Journal of Haematology. 181(5). 577–577. 1 indexed citations
20.
Mercado, Pablo, Julien Maizel, Christophe Beyls, et al.. (2017). Transthoracic echocardiography: an accurate and precise method for estimating cardiac output in the critically ill patient. Critical Care. 21(1). 136–136. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Murray Kornbluth Breakdown of academic impact, for papers by Karen MacKinnon Breakdown of academic impact, for papers by Zachary W. Fitch Breakdown of academic impact, for papers by Francesco Sollitto Breakdown of academic impact, for papers by Alfonsa Friera Breakdown of academic impact, for papers by Laura Franco Breakdown of academic impact, for papers by Chiara Simion Breakdown of academic impact, for papers by Jacqueline Szmuszkovicz Breakdown of academic impact, for papers by Shin-Yup Lee Breakdown of academic impact, for papers by V. Villena
Rankless by CCL
2026